Biomarkers in heart failure.

Nowadays, heart failure (HF) has an increasing prevalence, particularly in the elderly, and is becoming a clinical problem of epidemic proportion in terms of morbidity and mortality. Developing biological markers, that can aid in the diagnosis of HF and in the differentiation of congestive heart failure (CHF) from other causes of dyspnoea, will reduce the cost of health care. However, an ideal biomarker has not yet been identified.

[Usefulness of coronary angiography with multidetector computed tomography in the evaluation of aorto-coronary bypass patency].

Background: Coronary angiography is actually the gold standard to visualize coronary artery bypass graft patency and to detect bypass stenoses. However, it is an invasive examination that makes use of X-ray emission and it may lead to deleterious effects even at low dosage. Therefore, it is still needed a non-invasive examination with good diagnostic accuracy for the follow-up of patients with coronary artery bypass grafts.

Peripheral atherosclerosis is associated with the occurrence of restenosis after percutaneous coronary intervention.

Introduction: The aim of our study was to evaluate, in patients with proven coronary artery disease (CAD) and treated with elective percutaneous coronary intervention (PCI), whether the coexistence of asymptomatic carotid and femoral atherosclerotic lesions would provide prognostic information in terms of occurrence of restenosis.

Methods: We studied 104 patients with CAD (M/F=77/27), mean age 60.5+/-9 years.